New & Noteworthy

November 2012

Oxaliplatin Injection

Pfizer Inc

Pfizer Injectables announces that Oxaliplatin Injection, USP, has been approved by the FDA and added to the growing Pfizer Injectables oncology portfolio. To view full prescribing information for Oxaliplatin Injection, USP, as well as product information for all our injectable medicines, visit pfizerinjectables.com.

Request More Information

Current Issue